Dailypharm Live Search Close

Botulinum toxin by fraudulent means can be revoked

By Lee, Jeong-Hwan | translator Choi HeeYoung

21.09.28 17:46:44

°¡³ª´Ù¶ó 0
A bill initiated by Rep. Baek Jong-heon,

Reinforcement of regulations on handling and management


Regulations on handling and management, such as reporting high-risk pathogens such as botulinum toxin and anthrax, will be strengthened, and permission for bioterrorism infectious disease pathogens licensed by fraudulent methods will be revoked.

On the 28th, Baek Jong-heon (Busan Geumjeong-gu), a member of the National Assembly's Health and Welfare Committee, said that the "Partial Amendment to the Infectious Disease Prevention Act" has passed the plenary session of the National Assembly.

The current law regulates those who want to install and operate high-risk pathogen handling facilities to obtain or report permission from the head of the KDCA by safety management level.

Lee, Jeong-Hwan(junghwanss@dailypharm.com)
If you want to see the full article, please JOIN US (click)